Skip to main content

Do Patients on Upadacitinib Need Labs? Dr. Janet Pope

Jun 03, 2021 10:59 am

Dr. Janet Pope discusses abstract OP00128, "Integrated Laboratory Abnormality Profiles of Upadacitinib with up to 4.5 Year of Exposure in Patients with Rheumatoid Arthritis Treated in the Select Phase 3 Program", presented at the virtual EULAR 2021 meeting.


If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.